Lung cancer screening with low-dose CT can detect extensive coronary artery calcium, an independent predictor of all-cause ...

The non-small cell lung cancer (NSCLC) drug osimertinib (Tagrisso) was associated with an increased risk of therapy-related ...

When these cancers metastasize (spread) to the lungs, they are identified at the site of origin and not considered primary lung cancer. Certain heart problems—such as coronary artery disease, heart ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using ...

Heavy cigarette smokers died of heart disease at nearly twice the rate of those who had never smoked. The death rates from cancer of the lung were ... blameworthy than failure to suggest caution ...

A commonly prescribed medication for heart failure was linked to a lower risk of heart damage, or cardiotoxicity, among high-risk cancer patients undergoing chemotherapy treatment using ...

Wildfire smoke has long been known to exacerbate health problems like heart disease, lung conditions ... The devastating news of a cancer diagnosis understandably makes doctors and patients ...

An NHS mobile lung-cancer screening clinic in Gorton, Manchester. A lung-cancer screening programme that sees mobile clinics visit local communities in England has detected the disease earlier in ...

Patients with some of the most common lung diseases are substantially more likely to suffer a heart attack and develop other major heart problems according to new research. The team of heart and lung ...

The FINEARTS-HF trial included 46% female participants, improving female representation in heart failure research. Finerenone reduced heart failure events and mortality similarly in both sexes ...

Brain cancer originates in the brain and consists of brain cancer cells. But brain metastases from lung cancer occur when cancer cells break off from the tumor in the lungs and enter the ...

Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a newer class of medications used to treat type 2 diabetes. These ...